Grand Rapids, Michigan
Phase 1 cancer trials in Grand Rapids, MI
72 Phase 1 cancer studies are recruiting participants at sites in Grand Rapids as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Grand Rapids at a glance
- 72 studies are recruiting at a site in Grand Rapids.
- By phase: Early Phase 1 (1), Phase 1 (44), Phase 1/2 (27).
- By sponsor: industry (68), university, hospital or other (4).
- By research area: Breast Cancer (28), Lung Cancer (20), Prostate Cancer (10), Lymphoma (9), Melanoma (3), Pancreatic Cancer (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Grand Rapids
Basic details from each study's public record (the 30 most recently updated of 72). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- START - Midwest Cancer Research Center
- Registry record
- NCT06253871 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- BAMF Health
- Registry record
- NCT07020117 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- START Midwest
- Registry record
- NCT07488676 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study site
- South Texas Accelerated Research Therapeutics (START)
- Registry record
- NCT06270706 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- START Midwest - Oncology
- Registry record
- NCT06638307 · updated
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- START Midwest, LLC
- Registry record
- NCT06827236 · updated
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Immunomic Therapeutics, Inc.
- Study site
- START Midwest
- Registry record
- NCT07652242 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- South Texas Accelerated Research Therapeutics (START) Midwest
- Registry record
- NCT07029399 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- START Midwest, LLC
- Registry record
- NCT07318805 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- START Midwest
- Registry record
- NCT05579366 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- South Texas Accelerated Research Therapeutics (START) Midwest
- Registry record
- NCT06400472 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- START Midwest Cancer and Hematology Centers of W Michigan
- Registry record
- NCT06465069 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- BAMF Health Inc.
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- BAMF Health Inc.
- Registry record
- NCT07213791 · updated
A Study of MGC026 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study site
- START Midwest
- Registry record
- NCT06242470 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Grand Rapids, MI on ClinicalTrials.gov.
Lung cancer studies recruiting in Grand Rapids
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- South Texas Accelerated Research Therapeutics (START) Midwest
- Registry record
- NCT05786924 · updated
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- START Midwest, LLC
- Registry record
- NCT07903415 · updated
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- START | Midwest
- Registry record
- NCT06914128 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- START Midwest
- Registry record
- NCT06720987 · updated
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Inc
- Study site
- START Midwest
- Registry record
- NCT07094204 · updated
DBC-664 in Adult Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Duboce Biopharmaceuticals, Inc.
- Study site
- START Midwest
- Registry record
- NCT07705035 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Grand Rapids, MI on ClinicalTrials.gov.
Prostate cancer studies recruiting in Grand Rapids
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07332455 · updated
JUR-003 in Adult Patients With Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Juri Biosciences, Inc.
- Study site
- START Midwest
- Registry record
- NCT07824349 · updated
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Start Midwest
- Registry record
- NCT05818683 · updated
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- South Texas Accelerated Research Therapeutics, LLC (START)
- Registry record
- NCT06800313 · updated
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Start Midwest
- Registry record
- NCT07746713 · updated
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Aktis Oncology, Inc.
- Study site
- BAMF Health
- Registry record
- NCT07581184 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Grand Rapids, MI on ClinicalTrials.gov.
Melanoma studies recruiting in Grand Rapids
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Study site
- START Midwest, LLC
- Registry record
- NCT07584226 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Grand Rapids, MI on ClinicalTrials.gov.
Lymphoma studies recruiting in Grand Rapids
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
- Registry record
- NCT04726241 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Corewell Health ( Site 1001)
- Registry record
- NCT06395103 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Grand Rapids, MI on ClinicalTrials.gov.
Ask about studies near Grand Rapids
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Michigan
All Michigan locations
145 studies recruiting across 8 cities.
Detroit
55 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections